INDACATEROL - THE RAPID AND THE ULTRA-LONG ACTING B2-AGONIST FOR THE TREATMENT OF COPD

  • Mindaugas Vaitkus
DOI: https://doi.org/10.37499/PIA.382
Keywords: ultra-long acting beta 2 agonist, chronic obstructive pulmonary disease, inhalation therapy, indacaterol, Onbrez® Breezhaler®

Abstract

Indacaterolis a once-daily maintenance broncholdilator treatment of airflow obstruction in adult patients with chronic obstructive pulmonary disease. It has a relatively longer duration of action compared with existing long acting beta 2-agonists and a fast onset of action.

Author Biography

Mindaugas Vaitkus

Department of Pulmonology and Immunology, Medical Academy, Lithuanian University of Health Sciences

How to Cite
1.
Vaitkus M. INDACATEROL - THE RAPID AND THE ULTRA-LONG ACTING B2-AGONIST FOR THE TREATMENT OF COPD [Internet]. PIA 2013 May;12(1):46-49.[cited 2024 Nov. 22 ] Available from: http://pia.pulmoalerg.lt/index.php/PIA/article/view/382
Issue
Vol 12 No 1 (2013): Pulmonology, Immunology and Allergology
Section
Pharmacotherapy